Status:
WITHDRAWN
The Effect of Transcutaneous Magnetic Stimulation on Acute Pain.
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
University of Maryland, College Park
Conditions:
Pain Perception
Eligibility:
All Genders
18-80 years
Brief Summary
This is a single institution, single-blinded, long-term exploratory study using participant as his/her own control to evaluate and compare the potential analgesic effect on experimental heat pain of T...
Detailed Description
After subjects contact the office to express interest in being involved with this protocol, subjects will take the telephone screening questionnaire. Those who meet inclusion criteria with no exclusio...
Eligibility Criteria
Inclusion
- Healthy man or woman 18-80 years of age;
- Possess the ability to understand study procedures and comply with them for the entire length of the study;
- Women of childbearing age must use contraception for duration of study.
Exclusion
- History of diagnosis of heart disease, increased intracranial pressure, or structural abnormalities of the brain (e.g. tumor);
- History of epilepsy, seizure disorder, neurologic disease, cranial trauma or head surgery, or implanted hardware (including cardiac pacemakers, cardiac lines, medication pumps, or stimulators);
- Family history of seizures;
- Presence of metal anywhere deep to or on the skull (excluding the mouth);
- Any current or recent (\<6 weeks) or planned (within duration of study period) use of any of the following medications: imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, ketamine, gamma-hydroxybutyrate (GHB), and theophylline;
- History of peripheral neuropathy, e.g. Diabetic Neuropathy;
- Women who are pregnant or women of childbearing capacity who may become pregnant (i.e. not using contraception);
- Volunteers with communication disorders or non-English speakers;
- Current drug or alcohol use or dependence that, in the opinion of the investigators, would interfere with adherence to study requirements.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03777137
Start Date
October 1 2021
End Date
July 1 2027
Last Update
October 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopkiins Functional Neurosurgery Lab
Baltimore, Maryland, United States, 21212